A new postdoctoral position is available immediately in the laboratory of Dr. Jennifer Herington at Vanderbilt University Medical Center, which is focused on the discovery of novel therapeutics and the use of targeted drug delivery to inhibit uterine myometrial contractility for prevention of preterm labor.

The available position is to conduct exciting studies that will advance at a rapid pace to characterize the performance of new drug delivery systems (DDSs) to suppress uterine contractions that lead to preterm birth.  This is a collaborative project between an industrial partner that will fabricate drug conjugates for in vitro, ex vivo and in vivo testing in the laboratories of Drs. Herington and Todd Giorgio (Professor of Biomedical Engineering at Vanderbilt University, whose laboratory specializes on developing and testing advanced DDSs).

Candidates should have a recent Ph.D. degree with a strong background in pharmacology and a strong publication record. Individuals with experience in vitro cell-based assays, in vivo pharmacokinetic and pharmacodynamic studies will be given preference. Effectiveness in these high-level tasks will require the following skills (among others): primary cell isolation, cell culture, administration (intrauterine, intravenous, and subcutaneous) of treatments to mice, HPLC, LC-MS, sample collection at necropsy.  We value self-motivated, enthusiastic and collaborative team members.

Interested individuals should submit a single pdf including: a cover letter containing a summary of their prior work and a short paragraph of research interests along with a CV with information for 3 references.

Contact:

Jennifer Herington, PhD

Assistant Professor                                      

Division of Neonatology, Department of Pediatrics

Department of Pharmacology                                             

Jennifer.l.herington@vumc.org